SCHEMBL23609231

SCHEMBL23609231

C=CC(O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4cnc5[nH]ccc5c4)n3)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK7 P50613 17/20 0.67
▸ CCNH P51946 15/20 0.67
▸ CDK13 Q14004 2/20 0.53
▸ CDK12 Q9NYV4 2/20 0.53
▸ CCNT1 O60563 1/20 0.45
▸ CCNK O75909 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ CCNB1 P14635 1/20 0.45
▸ CCNA2 P20248 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ MAPK8 P45983 1/20 0.45
▸ MAPK9 P45984 1/20 0.45
▸ CDK9 P50750 1/20 0.45
▸ MNAT1 P51948 1/20 0.45
▸ CDK5 Q00535 1/20 0.45
▸ CDK5R1 Q15078 1/20 0.45
▸ MAP3K11 Q16584 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ PIP4K2A P48426 1/20 0.45
▸ PIP4K2B P78356 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18313107 0.88 CDK7 (0.76) CDK7CCNHCDK13CDK12CCNT1
SCHEMBL23609218 0.81 CDK7 (0.77) CDK7CCNHCDK13CDK12CCNT1
SCHEMBL18313429 0.80 CDK7 (1.00) CDK7CCNHCDK13CDK12CCNT1
SCHEMBL22606038 0.78 CDK7 (0.68) CDK7CCNHCDK13CDK12CCNT1
SCHEMBL20211539 0.74 CDK7 (0.89) CDK7CCNHCDK13CDK12CCNT1
SCHEMBL20211541 0.74 CDK7 (0.89) CDK7CCNHCDK13CDK12CCNT1
SCHEMBL14979755 0.74 PDGFRA (0.59) CDK7CCNHMAPK8MAPK9EGFR
SCHEMBL20225392 0.73 CDK7 (0.52) CDK7CCNHCDK1CDK2MAPK8
SCHEMBL18346151 0.73 CDK7 (0.56) CDK7CCNHEGFRPIP4K2APIP4K2B
SCHEMBL18313468 0.71 CDK7 (0.89) CDK7CCNHCDK13CDK12CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133601-A1 THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-07-01 — — WO disclosed
Send feedback